Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (13)

2024

  1. A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24

    BJU International, Vol. 134, Núm. 4, pp. 568-577

  2. Is trimodal therapy the current standard for muscle-invasive bladder cancer?

    Actas Urologicas Espanolas, Vol. 48, Núm. 5, pp. 345-355

  3. Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach

    Radiotherapy and Oncology, Vol. 190

  4. Recommendations on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Patient Selection

    Actas Urologicas Espanolas, Vol. 48, Núm. 9, pp. 623-631

2023

  1. Coronavirus disease 2019 and lung cancer: where are we?

    Exploration of Targeted Anti-tumor Therapy, Vol. 4, Núm. 5, pp. 1082-1094

  2. Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?

    Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e93-e103

  3. Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer

    Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 718-732

2022

  1. The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging in Primary and Recurrent Prostate Cancer: A Systematic Review of the Literature

    European Urology Focus, Vol. 8, Núm. 4, pp. 942-957

2021

  1. Effect of covid-19 on thoracic oncology surgery in Spain: A Spanish thoracic surgery society (sect) survey

    Cancers, Vol. 13, Núm. 12

  2. Targeted therapy moves to earlier stages of non-small-cell lung cancer: Emerging evidence, controversies and future challenges

    Future Oncology, Vol. 17, Núm. 30, pp. 4011-4025

2020

  1. Clinical applications of molecular biomarkers in prostate cancer

    Cancers, Vol. 12, Núm. 6, pp. 1-25

  2. Genetic testing for the clinician in prostate cancer

    Expert Review of Molecular Diagnostics, Vol. 20, Núm. 9, pp. 933-946

  3. Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 405-411